Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 12/20 | 0.47 |
| ▸ | KIFC1 | Q9BW19 | 2/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8337386 | 0.98 | LRRK2 (0.49) | LRRK2KIFC1ABCG2POLBLMNA | |
| SCHEMBL8337399 | 0.92 | LRRK2 (0.49) | LRRK2KIFC1ABCG2POLBCTSB | |
| SCHEMBL5926822 | 0.91 | KIFC1 (0.55) | LRRK2KIFC1ABCG2 | |
| SCHEMBL5927081 | 0.90 | ABCG2 (0.54) | LRRK2KIFC1ABCG2POLBLMNA | |
| SCHEMBL8337545 | 0.90 | LRRK2 (0.38) | LRRK2KIFC1ABCG2POLBLMNA | |
| SCHEMBL5927055 | 0.89 | KIFC1 (0.55) | LRRK2KIFC1ABCG2 | |
| SCHEMBL5927541 | 0.89 | KIFC1 (0.53) | LRRK2KIFC1ABCG2 | |
| SCHEMBL8337866 | 0.89 | PTPN11 (0.44) | LRRK2ABCG2POLBLMNANPSR1 | |
| SCHEMBL5926387 | 0.89 | ABCG2 (0.56) | LRRK2KIFC1ABCG2POLBLMNA | |
| SCHEMBL5926514 | 0.88 | KIFC1 (0.52) | LRRK2KIFC1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004014844-A2 | ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION | TRANSTECH PHARMA, INC. (US) | 2004-02-19 | — | — | WO | disclosed |